Liposomes containing oligonucleotides

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

436 71, 436829, 536 231, 536 245, A61K 9127, C07H 2104

Patent

active

061269654

ABSTRACT:
It is possible to radiosensitize tumor cells by administration of compositions containing the Human antisense c-raf-1 oligodeoxyribonucleotide (ODN/oligo) sequence: 5'-GTGCTCCATTGATGC-3' (seq. #1) wherein only the end bases are phosphorylated is a preferred embodiment. Antisense sequences of up to 40 bases which containing this sequence may be used in accord with the teachings of this disclosure. Compositions comprising a cationic liposome of dimethyldioctadecyl ammonium bromide, phosphatidylcholine and cholesterol may be used as a carrier system. The liposomes provide a new carrier system that is particularly useful for administration of sequences for therapy.

REFERENCES:
patent: 5756122 (1998-05-01), Thierry et al.
patent: 5827703 (1998-10-01), Deb et al.
Maher et al., Specific hybridization arrest of dihydrofolate reductase mRNA in vitro using antisense RNA or antisense oligonucleotides, Archives of Biochemistry and Biophysics, vol. 253 (1), pp. 214-220, Feb. 15, 1987.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Liposomes containing oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liposomes containing oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomes containing oligonucleotides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-192545

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.